The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 26, 2025
Filed:
Jun. 14, 2024
Applicant:
Atai Therapeutics, Inc., New York, NY (US);
Inventors:
Christopher G. Witowski, Tampa, FL (US);
Jacqueline L. Salm, Tampa, FL (US);
Assignee:
Atai Therapeutics, Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4045 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/20 (2006.01); A61K 9/70 (2006.01); A61K 31/405 (2006.01); A61K 31/48 (2006.01); A61K 31/55 (2006.01); A61K 31/675 (2006.01); C07D 209/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4045 (2013.01); A61K 9/0043 (2013.01); A61K 9/06 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/7061 (2013.01); A61K 9/7069 (2013.01); A61K 31/405 (2013.01); A61K 31/48 (2013.01); A61K 31/55 (2013.01); A61K 31/675 (2013.01); C07D 209/16 (2013.01);
Abstract
Pharmaceutical formulations of novel indole compounds and psilocybin analogs are manufactured, provided in novel oral, transdermal, and nasal pharmaceutical compositions for use to treat neurological, mood or abuse diseases and disorders.